glp-1 drugs uk One in ten British adults used or interested in medications for weight loss GLP-1 drugs may change addiction
Description
Originally developed for managing blood glucose levels in people with type 2 diabetes, GLP-1 receptor agonists like Ozempic have demonstrated impressive results in supporting healthy weight loss

The SURMOUNT-5 head-to-head trial confirmed tirzepatide outperforms semaglutide by approximately 6 percentage points on average weight loss

Research from 2023 found that people lost Two popular GLP-1 medications, Ozempic and Mounjaro (tirzepatide), only have FDA approval for the management of type 2 diabetes

Recent research shows that bitter substances that activate TAS2R38 can also increase glucagon-like peptide 1 release.[ref] Related article : Bitter Taste Receptors Berberine: One bitter substance that activates TAS2R38 is berberine .[ref] Berberine is readily available as a supplement and also impacts blood glucose levels

[DOI] [PMC free article] [PubMed] [Google Scholar] 259.Keyserling T.C., Samuel-Hodge C.D., Pitts S.J., Garcia B.A., Johnston L.F., Gizlice Z., Miller C.L., Braxton D.F., Evenson K.R., Smith J.C., et al
